Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 May;41(5):1140–1142. doi: 10.1128/aac.41.5.1140

Multiple antibiotic resistance in Stenotrophomonas maltophilia.

A Alonso 1, J L Martínez 1
PMCID: PMC163865  PMID: 9145884

Abstract

A cryptic multidrug resistance (MDR) system in Stenotrophomonas maltophilia, the expression of which is selectable by tetracycline, is described. Tetracycline resistance was the consequence of active efflux of the antibiotic, and it was associated with resistance to quinolones and chloramphenicol, but not to aminoglycosides or beta-lactam antibiotics. MDR is linked to the expression of an outer membrane protein (OMP54) both in a model system and in multidrug-resistant clinical isolates.

Full Text

The Full Text of this article is available as a PDF (428.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arpi M., Victor M. A., Møller J. K., Jønsson V., Hansen M. M., Peterslund N. A., Bruun B. Changing etiology of bacteremia in patients with hematological malignancies in Denmark. Scand J Infect Dis. 1994;26(2):157–162. doi: 10.3109/00365549409011779. [DOI] [PubMed] [Google Scholar]
  2. Bergogne-Bérézin E., Decré D., Joly-Guillou M. L. Opportunistic nosocomial multiply resistant bacterial infections--their treatment and prevention. J Antimicrob Chemother. 1993 Jul;32 (Suppl A):39–47. doi: 10.1093/jac/32.suppl_a.39. [DOI] [PubMed] [Google Scholar]
  3. Cohen S. P., McMurry L. M., Hooper D. C., Wolfson J. S., Levy S. B. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Chemother. 1989 Aug;33(8):1318–1325. doi: 10.1128/aac.33.8.1318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Denton M., Todd N. J., Littlewood J. M. Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients. Eur J Clin Microbiol Infect Dis. 1996 May;15(5):402–405. doi: 10.1007/BF01690098. [DOI] [PubMed] [Google Scholar]
  5. Fukuoka T., Masuda N., Takenouchi T., Sekine N., Iijima M., Ohya S. Increase in susceptibility of Pseudomonas aeruginosa to carbapenem antibiotics in low-amino-acid media. Antimicrob Agents Chemother. 1991 Mar;35(3):529–532. doi: 10.1128/aac.35.3.529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. George A. M. Multidrug resistance in enteric and other gram-negative bacteria. FEMS Microbiol Lett. 1996 May 15;139(1):1–10. doi: 10.1111/j.1574-6968.1996.tb08172.x. [DOI] [PubMed] [Google Scholar]
  7. Goldman J. D., White D. G., Levy S. B. Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones. Antimicrob Agents Chemother. 1996 May;40(5):1266–1269. doi: 10.1128/aac.40.5.1266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hamzehpour M. M., Pechere J. C., Plesiat P., Köhler T. OprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1995 Nov;39(11):2392–2396. doi: 10.1128/aac.39.11.2392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Heath T., Currie B. Nosocomial and community-acquired Xanthomonas maltophilia infection in tropical Australia. J Hosp Infect. 1995 Aug;30(4):309–313. doi: 10.1016/0195-6701(95)90266-x. [DOI] [PubMed] [Google Scholar]
  10. Karpati F., Malmborg A. S., Alfredsson H., Hjelte L., Strandvik B. Bacterial colonisation with Xanthomonas maltophilia--a retrospective study in a cystic fibrosis patient population. Infection. 1994 Jul-Aug;22(4):258–263. doi: 10.1007/BF01739911. [DOI] [PubMed] [Google Scholar]
  11. Lecso-Bornet M., Pierre J., Sarkis-Karam D., Lubera S., Bergogne-Berezin E. Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro. Antimicrob Agents Chemother. 1992 Mar;36(3):669–671. doi: 10.1128/aac.36.3.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lewis K. Multidrug resistance pumps in bacteria: variations on a theme. Trends Biochem Sci. 1994 Mar;19(3):119–123. doi: 10.1016/0968-0004(94)90204-6. [DOI] [PubMed] [Google Scholar]
  13. Li X. Z., Livermore D. M., Nikaido H. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob Agents Chemother. 1994 Aug;38(8):1732–1741. doi: 10.1128/aac.38.8.1732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lomovskaya O., Lewis K., Matin A. EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB. J Bacteriol. 1995 May;177(9):2328–2334. doi: 10.1128/jb.177.9.2328-2334.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ma D., Cook D. N., Alberti M., Pon N. G., Nikaido H., Hearst J. E. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol Microbiol. 1995 Apr;16(1):45–55. doi: 10.1111/j.1365-2958.1995.tb02390.x. [DOI] [PubMed] [Google Scholar]
  16. Ma D., Cook D. N., Hearst J. E., Nikaido H. Efflux pumps and drug resistance in gram-negative bacteria. Trends Microbiol. 1994 Dec;2(12):489–493. doi: 10.1016/0966-842x(94)90654-8. [DOI] [PubMed] [Google Scholar]
  17. Maningo E., Watanakunakorn C. Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units. J Infect. 1995 Sep;31(2):89–92. doi: 10.1016/s0163-4453(95)91985-6. [DOI] [PubMed] [Google Scholar]
  18. Neu H. C. Quinolone antimicrobial agents. Annu Rev Med. 1992;43:465–486. doi: 10.1146/annurev.me.43.020192.002341. [DOI] [PubMed] [Google Scholar]
  19. Nikaido H. Multidrug efflux pumps of gram-negative bacteria. J Bacteriol. 1996 Oct;178(20):5853–5859. doi: 10.1128/jb.178.20.5853-5859.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science. 1994 Apr 15;264(5157):382–388. doi: 10.1126/science.8153625. [DOI] [PubMed] [Google Scholar]
  21. Paton R., Miles R. S., Amyes S. G. Biochemical properties of inducible beta-lactamases produced from Xanthomonas maltophilia. Antimicrob Agents Chemother. 1994 Sep;38(9):2143–2149. doi: 10.1128/aac.38.9.2143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Paulsen I. T., Brown M. H., Skurray R. A. Proton-dependent multidrug efflux systems. Microbiol Rev. 1996 Dec;60(4):575–608. doi: 10.1128/mr.60.4.575-608.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Seoane A. S., Levy S. B. Characterization of MarR, the repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli. J Bacteriol. 1995 Jun;177(12):3414–3419. doi: 10.1128/jb.177.12.3414-3419.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Smit W. J., Boquest A. L., Geddes J. E., Tosolini F. A. The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management. Pathology. 1994 Jul;26(3):321–324. doi: 10.1080/00313029400169751. [DOI] [PubMed] [Google Scholar]
  25. Vartivarian S. E., Papadakis K. A., Anaissie E. J. Stenotrophomonas (Xanthomonas) maltophilia urinary tract infection. A disease that is usually severe and complicated. Arch Intern Med. 1996 Feb 26;156(4):433–435. [PubMed] [Google Scholar]
  26. Vartivarian S., Anaissie E., Bodey G., Sprigg H., Rolston K. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob Agents Chemother. 1994 Mar;38(3):624–627. doi: 10.1128/aac.38.3.624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wilcox M. H., Winstanley T. G., Spencer R. C. Outer membrane protein profiles of Xanthomonas maltophilia isolates displaying temperature-dependent susceptibility to gentamicin. J Antimicrob Chemother. 1994 Mar;33(3):663–666. doi: 10.1093/jac/33.3.663. [DOI] [PubMed] [Google Scholar]
  28. Yao J. D., Louie M., Louie L., Goodfellow J., Simor A. E. Comparison of E test and agar dilution for antimicrobial susceptibility testing of Stenotrophomonas (Xanthomonas) maltophilia. J Clin Microbiol. 1995 May;33(5):1428–1430. doi: 10.1128/jcm.33.5.1428-1430.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES